93 74 Pill - white round, 7mm
Pill with imprint 93 74 is White, Round and has been identified as Zolpidem Tartrate 10 mg. It is supplied by Teva Pharmaceuticals USA.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 10 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for 93 74
Zolpidem Tartrate
- Imprint
- 93 74
- Strength
- 10 mg
- Color
- White
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-0074
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 400,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "93 74"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,048)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
- Zolpidem drug information
- Zolpidem (Oral) (Advanced Reading)
- Zolpidem (Oromucosal, Sublingual) (Advanced Reading)
- Zolpidem Extended-Release Tablets
- Zolpidem Oral Spray
Other brands
Ambien, Ambien CR, Zolpimist, Edluar, Intermezzo
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Edluar, Intermezzo
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
